apomorphine (Crossject)

N/A

Report date: 2025/01/26 18:46:03
NME

Base Information

Drug Nameapomorphine (Crossject)
Drug Alias NameZENEO-apomorphineapomorphine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsParalysisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossject
China Registration ClassN/A

Develop Information

Active CompaniesCrossject
Inactive CompaniesN/A
Active IndicationsParalysisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A